Login
The Pfizer COVID-19 vaccine was approved by the FDA for use in children 5-11 years. Since about 1 out of 4 new COVID-19 cases are for children under the age of 18 and the previous age indication was 12 years and older, this is a very important event in the next stage of preventing the spread and complications associated with COVID-19. The delta variant seemed to cause additional COVID19 cases with most of the severe COVID disease occuring in the unvaccinated.
Pediatric offices should leverage this opportunity to help by identifying and contacting all parents with children that are over 5 years of age and who did not receive a vaccine. The PediatricXpress system by PhysicianXpress has a new tool that helps the staff of Pediatric Offices identify patients to call so that an Office manager or practice owner can effectively implement an outbound call campaign. While many parents are very excited about this opportunity to vaccinate their 5+ year old children, some parents are vaccine hesitant or anti-vaccines. It is important to leverage this tool as well as insure the staff conducting the outbound call training is familiar and confident in contacting the parents. Providing words and references from creditable sites such as the CDC can help an office staff member speak with confidence when interacting with parents related to questions on the COVID-19 Vaccine. There are a number of great tools to understand the impact of COVID-19 including information related to the 5-11 year old vaccine.
COVID-19 Vaccination for Children 5-11 Years Old | CDC
The updated age indication for the Pfizer COVID-19 vaccine is a great opportunity for Pediatric offices to help immunize children 5 years and older.
